Citations for
1CLDN2, IL22
IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression.
Wang Y, Mumm JB, Herbst R, Kolbeck R, Wang Y.
J Immunol 199(9):3316-3325. doi: 10.4049/jimmunol.1700152. Epub 2017 Sep 22. 2017
2CLDN2, CLDN4, EGF
EGF regulates claudin-2 and -4 expression through Src and STAT3 in MDCK cells.
García-Hernández V, Flores-Maldonado C, Rincon-Heredia R, Verdejo-Torres O, Bonilla-Delgado J, Meneses-Morales I, Gariglio P, Contreras RG.
J Cell Physiol 230(1):105-15. doi: 10.1002/jcp.24687. 2015
3CLDN1, CLDN2, CLDN3, CLDN4
Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin.
Hintsala HR, Siponen M, Haapasaari KM, Karihtala P, Soini Y.
Int J Clin Exp Pathol 6(12):2855-63. eCollection 2013. 2013
4CLDN2, MYLK
Claudin-2 regulates colorectal inflammation via myosin light chain kinase-dependent signaling.
Nishida M, Yoshida M, Nishiumi S, Furuse M, Azuma T.
Dig Dis Sci 58(6):1546-59. doi: 10.1007/s10620-012-2535-3. Epub 2013 Jan 11. 2013
5CLDN2
Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes.
Tabariès S, Dupuy F, Dong Z, Monast A, Annis MG, Spicer J, Ferri LE, Omeroglu A, Basik M, Amir E, Clemons M, Siegel PM.
Mol Cell Biol 32(15):2979-91. doi: 10.1128/MCB.00299-12. Epub 2012 May 29. 2012
6CLDN16, CLDN2, CLDN4
Claudin-2 forms homodimers and is a component of a high molecular weight protein complex.
Van Itallie CM, Mitic LL, Anderson JM.
J Biol Chem 286(5):3442-50. Epub 2010 Nov 22. 2011
7CDX2, CLDN2, IL6
Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium.
Suzuki T, Yoshinaga N, Tanabe S.
J Biol Chem 286(36):31263-71. Epub 2011 Jul 19. 2011
8CLDN2
Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.
Dhawan P, Ahmad R, Chaturvedi R, Smith JJ, Midha R, Mittal MK, Krishnan M, Chen X, Eschrich S, Yeatman TJ, Harris RC, Washington MK, Wilson KT, Beauchamp RD, Singh AB.
Oncogene 30(29):3234-47. doi: 10.1038/onc.2011.43. Epub 2011 Mar 7. 2011
9CLDN2, CSDA, SYMPK
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression.
Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V, Pélegrin A, Bourgaux JF, Pannequin J, Joubert D, Hollande F.
Proc Natl Acad Sci U S A 107(6):2628-33. Epub 2010 Jan 25.PMID: 20133805 2010
10CLDN2
Downregulation of claudin-2 expression in renal epithelial cells by metabolic acidosis.
Balkovetz DF, Chumley P, Amlal H.
Am J Physiol Renal Physiol 297(3):F604-11. Epub 2009 Jul 8. 2009
11CLDN2
Molecular basis for cation selectivity in claudin-2-based pores.
Yu AS.
Ann N Y Acad Sci 1165:53-7. 2009
12CLDN2, RPS6KA6
Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
Thakur A, Sun Y, Bollig A, Wu J, Biliran H, Banerjee S, Sarkar FH, Liao DJ.
Clin Cancer Res 14(14):4427-36. 2008
13CLDN1, CLDN2
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation.
Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR.
Lab Invest 88(10):1110-20. Epub 2008 Aug 18. 2008
14CLDN2
Claudin 2 mRNA and protein are present in human keratinocytes and may be regulated by all-trans-retinoic acid.
Telgenhoff D, Ramsay S, Hilz S, Slusarewicz P, Shroot B.
Skin Pharmacol Physiol 21(4):211-7. Epub 2008 May 29. 2008
15CLDN2
Expression of claudin-2 in the multistage process of gastric carcinogenesis.
Song X, Li X, Tang Y, Chen H, Wong B, Wang J, Chen M.
Histol Histopathol 23(6):673-82. 2008
16CLDN12, CLDN2
Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes.
Fujita H, Sugimoto K, Inatomi S, Maeda T, Osanai M, Uchiyama Y, Yamamoto Y, Wada T, Kojima T, Yokozaki H, Yamashita T, Kato S, Sawada N, Chiba H.
Mol Biol Cell 19(5):1912-21. Epub 2008 Feb 20.PMID: 18287530 2008
17CLDN2, RBBP7, RPS6KA6
Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer.
Thakur A, Rahman KW, Wu J, Bollig A, Biliran H, Lin X, Nassar H, Grignon DJ, Sarkar FH, Liao JD.
Mol Cancer Res 5(2):171-81. 2007
18CLDN1, CLDN2
Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.
Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, Nabeshima K, Iwasaki H, Kuroki M.
Anticancer Res 27(6A):3729-34.PMID: 17970035 2007
19CLDN1, CLDN12, CLDN14, CLDN18, CLDN2, CLDN3, CLDN6, CLDN8, CLDN9
Expression patterns of claudins, tight junction adhesion molecules, in the inner ear.
Kitajiri SI, Furuse M, Morita K, Saishin-Kiuchi Y, Kido H, Ito J, Tsukita S.
Hear Res 187(1-2):25-34.PMID: 14698084 2004
20CLDN2
Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha.
Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC.
J Biol Chem 277(24):21361-70. 2002
21CLDN1, CLDN10, CLDN11, CLDN12, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN21, CLDN22, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9
Claudins create charge-selective channels in the paracellular pathway between epithelial cells.
Colegio OR, Van Itallie CM, McCrea HJ, Rahner C, Anderson JM.
Am J Physiol Cell Physiol 283(1):C142-7. 2002
22CLDN1, CLDN2, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9
Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands.
Morita K, Furuse M, Fujimoto K, Tsukita S.
Proc Natl Acad Sci U S A 96(2):511-6. 1999
23CLDN1, CLDN10, CLDN2, CLDN3
Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions.
Kubota K, Furuse M, Sasaki H, Sonoda N, Fujita K, Nagafuchi A, Tsukita S.
Curr Biol 9(18):1035-8. 1999
24CLDN2, HNRNPAB, PWP1
A pancreatic cancer-specific expression profile.
Gress TM, Muller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H,Buchler M, Adler G, Lehrach H.
Oncogene 13(8):1819-30. 1996